I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| erythrocyte | 6 studies | 32% ± 18% | |
| endothelial cell | 5 studies | 25% ± 10% | |
| epithelial cell | 5 studies | 38% ± 15% | |
| natural killer cell | 5 studies | 23% ± 7% | |
| type II pneumocyte | 5 studies | 27% ± 17% | |
| CD8-positive, alpha-beta T cell | 5 studies | 18% ± 4% | |
| plasma cell | 4 studies | 28% ± 13% | |
| plasmablast | 4 studies | 41% ± 21% | |
| pancreatic A cell | 4 studies | 26% ± 9% | |
| fibroblast | 4 studies | 24% ± 9% | |
| ciliated cell | 4 studies | 28% ± 7% | |
| conventional dendritic cell | 3 studies | 28% ± 11% | |
| non-classical monocyte | 3 studies | 20% ± 1% | |
| erythroblast | 3 studies | 40% ± 23% | |
| effector CD8-positive, alpha-beta T cell | 3 studies | 16% ± 1% | |
| goblet cell | 3 studies | 23% ± 5% |
